Pathogenesis and Targeted Therapy of Neurodegenerative Diseases
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 14
Special Issue Editor
Interests: molecular biology; cell biology; cell culture; tissue culture apoptosis; cell signalling; genetics; biochemistry; medicinal chemistry; biology of cancer and neurodegenerative diseases; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), represent a growing global health concern due to their increasing prevalence and lack of curative treatments. These disorders are characterized by a progressive loss of neurons and synaptic function, leading to debilitating cognitive and motor impairments. Recent advances in molecular neuroscience have uncovered critical mechanisms underlying disease pathogenesis, including protein misfolding, mitochondrial dysfunction, oxidative stress, and neuroinflammation. Understanding these pathways opens the door to the development of targeted therapies that aim not only to alleviate symptoms but also to modify disease progression. This Special Issue invites original research articles, reviews, and perspectives that explore the molecular mechanisms of neurodegeneration and innovative therapeutic strategies. Contributions highlighting novel biomarkers, emerging therapeutic targets, or translational approaches are particularly encouraged.
Dr. Wioletta Rozpędek-Kamińska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- neurodegenerative diseases
- targeted therapy
- molecular mechanisms
- disease-modifying treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
